Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CareDx, Inc. (CDNA)
|
Add to portfolio |
|
|
|
| Price: |
$75.06
| | Metrics |
| OS: |
54.2
|
M
| |
-21
|
% ROE
|
| Market cap: |
$4.07
|
B
| |
-32
|
% ROIC
|
|
Net cash:
|
$478
|
M
| |
$8.82
|
per share
|
|
EV:
|
$3.59
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($87.6)
|
M
| |
|
|
| EPS |
($1.57)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 321.8 | 296.4 | 192.2 | 127.1 | 76.6 | 76.6 | 48.3 | 40.6 |
| Revenue growth | 8.6% | 54.2% | 51.3% | 66.0% | 58.4% | | 18.9% | 44.4% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 33.0 | 21.4 | 0.0 |
| Gross profit | 321.8 | 296.4 | 192.2 | 127.1 | 76.6 | 43.6 | 27.0 | 40.6 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 56.9% | 55.8% | 100.0% |
| Sales and marketing | 96.0 | 77.2 | 53.9 | 38.9 | 21.7 | 21.7 | 12.8 | 11.2 |
| Research and development | 90.4 | 76.5 | 48.9 | 30.7 | 14.5 | 14.5 | 12.4 | 12.4 |
| General and administrative | 100.4 | 75.0 | 48.8 | 36.5 | 23.0 | 23.0 | 20.1 | 20.7 |
| EBITA | -71.0 | -23.9 | -17.7 | -20.9 | -13.2 | -15.6 | -15.7 | -23.1 |
| EBITA margin | -22.1% | -8.1% | -9.2% | -16.5% | -17.2% | -20.3% | -32.6% | -56.8% |
| Amortization of intangibles | 6.2 | 5.8 | 4.8 | 3.6 | 2.4 | | 2.6 | 1.7 |
| EBIT | -77.2 | -29.7 | -22.5 | -24.5 | -15.6 | -15.6 | -18.3 | -24.8 |
| EBIT margin | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -20.3% | -37.9% | -61.0% |
| Pre-tax income | -76.2 | -32.1 | -19.8 | -23.9 | -48.2 | -48.2 | -57.3 | -41.4 |
| Income taxes | 0.4 | -1.4 | -1.0 | -2.0 | -1.4 | -1.4 | -1.7 | -1.6 |
| Tax rate | | 4.4% | 5.2% | 8.3% | 3.0% | 3.0% | 3.0% | 3.9% |
| Net income | -76.6 | -30.7 | -18.7 | -22.0 | -46.8 | -46.8 | -55.5 | -39.5 |
| Net margin | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -61.1% | -114.8% | -97.1% |
| |
| Diluted EPS | ($1.44) | ($0.59) | ($0.40) | ($0.52) | ($1.31) | ($1.31) | ($2.38) | ($2.39) |
| Shares outstanding (diluted) | 53.3 | 52.2 | 46.5 | 42.2 | 35.6 | 35.7 | 23.3 | 16.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|